Use fundamental data analysis to check out all available financial ratios of Micromedic Technologies to find out if markets are presently mispricing the entity. We found twenty-nine available fundamentals for Micromedic Technologies which can be compared to its peers in the industry. To make sure the equity is not overpriced, please verify all Micromedic Technologies Ltd fundamentals including its Shares Outstanding, Price to Book, Revenue, as well as the relationship between Price to Earning and Price to Sales . Use Micromedic Technologies to enhance returns of your portfolios. The stock experiences very speculative upward sentiment.. Check odds of Micromedic Technologies to be traded at S62.5 in 30 days
Micromedic Technologies Company Summary
Micromedic Technologies competes with Brainsway Ltd, Exalenz Bioscience, and . Micromedic Technologies Ltd. engages in the development and commercialization of in vitro cancer diagnostic products and solutions in Israel. In addition, it offers gene expression, and biomarker and histochemical assays for early cancer detection and personalized medicine. Micromedic Technologies operates under Diagnostics Research classification in Israel and is traded on Tel Aviv Stock Exchange.
Micromedic Technologies Current Valuation vs Total Debt
Micromedic Technologies Ltd is regarded fourth in current valuation category among related companies. It is regarded fourth in total debt category among related companies making up about 0.19 of Total Debt per Current Valuation. The ratio of Current Valuation to Total Debt for Micromedic Technologies Ltd is roughly 5.32
Micromedic Technologies Systematic Risk